Choice of GPIIb/IIIa antagonist in percutaneous coronary intervention: how should economic criteria be factored in?

Author: Pen Claude   Lilliu Hervé  

Publisher: Springer Publishing Company

ISSN: 0928-1231

Source: Pharmacy World and Science, Vol.27, Iss.2, 2005-04, pp. : 83-91

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract